MedTrace Logo

Timing of Initiation of Continuous Glucose Monitoring in Established Pediatric Diabetes (The CGM TIME Trial)

NCT01295788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2021-06-02

No results posted yet for this study

Summary

The investigators hypothesize that REAL-Time Continuous Glucose Monitoring (RT-CGM) will be more effective if introduced in children and adolescents with established diabetes at the same time as they are starting pump therapy. This randomized controlled trial will compare the effectiveness of simultaneous vs delayed introduction of RT-CGM in children and adolescents with type 1 diabetes who are starting insulin pump therapy.

Conditions

Interventions

DEVICE

Simultaneous RT-CGM and Pump Initiation

Subjects in this group will start using RT-CGM at the same time as they initiate insulin pump therapy.

DEVICE

Delayed Initiation of RT-CGM

Subjects in this group will start using RT-CGM 6 months after initiation of insulin pump therapy.

Sponsors & Collaborators

  • Juvenile Diabetes Research Foundation

    collaborator OTHER

  • Canadian Clinical Trial Network

    collaborator UNKNOWN

  • Children's Hospital of Eastern Ontario

    lead OTHER

Principal Investigators

  • Margaret L Lawson, MD · Children's Hospital of Eastern Ontario

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2014-06-30
Completion
2017-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01295788 on ClinicalTrials.gov